The economic burden of post-endoscopic retrograde cholangiopancreatography (ERCP) procedure infections in Italy

Authors

  • Paolo Sciattella Centre for Economics and International Studies – Economic Evaluation and Health Technology Assessment (EEHTA-CEIS), University of Rome “Tor Vergata”, Rome - Italy
  • Annarosa Fornero Department of Hospital Pharmacy, Città della Salute e della Scienza di Torino, Turin - Italy
  • Susanna Marzia Adele Giordano Department of Hospital Pharmacy, Città della Salute e della Scienza di Torino, Turin - Italy
  • Claudio Giovanni De Angelis Department of General and Specialist Medicine, Gastroenterologia-U, Città della Salute e della Scienza di Torino, Turin - Italy
  • Francesco Cattel Department of Hospital Pharmacy, Città della Salute e della Scienza di Torino, Turin - Italy https://orcid.org/0000-0002-9205-8917

DOI:

https://doi.org/10.33393/grhta.2024.3186

Keywords:

Economic burden, Endoscopic retrograde cholangiopancreatography, Healthcare resource utilization, Multidrug resistant, Post-ERCP infections, Real-world data

Abstract

Introduction: The infections of multidrug-resistant organisms (MDROs) associated with duodenoscopes during endoscopic retrograde cholangiopancreatography (ERCP) procedure have become a significant cause for concern, especially in fragile patients. While the clinical impacts of these infections are well-documented, their economic implications remain underexplored. This study assesses the incidence and economic burden of post-ERCP infections in Italy using an administrative database.

Methods: We conducted a retrospective observational study using administrative databases from A.O.U. Città della Salute e della Scienza di Torino. The study included all patients who underwent their first inpatient ERCP between 2018 and 2021. Infections were identified using ICD-9-CM codes for Pseudomonas aeruginosaClostridium difficileEscherichia coliKlebsiella spp., and Staphylococcus aureus. A 1-year follow-up was defined in order to estimate healthcare resource utilization and related costs, including readmissions, drug prescriptions, and outpatient specialist and laboratory services.

Results: The study included 686 inpatient ERCP cases, an overall infection rate of 4.2% was observed. Higher infection rates were observed in women (4.6%), patients over 70 years old (4.6%), emergency admissions (5.1%), and transplant patients (19.1%). The average hospital stay doubled for infected patients (24.3 vs. 11.3 days; p=0.001). Post-ERCP infections led to a 28% increase in average costs (€12,256 vs. €9,561; p=0.048). With an annual volume of 25,000 ERCP procedures, post-ERCP infections in Italy contribute approximately €2.9 million in additional direct costs per year.

Conclusion: Post-ERCP infections impose substantial financial burdens on the healthcare system, underscoring the critical importance of implementing cost-effective prevention strategies to mitigate this public health threat in Italy.

Downloads

Download data is not yet available.

References

Anderson MA, Fisher L, Jain R, et al; ASGE Standards of Practice Committee. Complications of ERCP. Gastrointest Endosc. 2012;75(3):467-473. https://doi.org/10.1016/j.gie.2011.07.010 PMID:22341094

Rauwers AW, Voor In ’t Holt AF, Buijs JG, et al. High prevalence rate of digestive tract bacteria in duodenoscopes: a nationwide study. Gut. 2018;67(9):1637-1645. https://doi.org/10.1136/gutjnl-2017-315082 PMID:29636382

Rauwers AW, Troelstra A, Fluit AC, et al. Independent root-cause analysis of contributing factors, including dismantling of 2 duodenoscopes, to investigate an outbreak of multidrug-resistant Klebsiella pneumoniae. Gastrointest Endosc. 2019;90(5):793-804. https://doi.org/10.1016/j.gie.2019.05.016 PMID:31102643

Chandra S, Klair JS, Soota K, Livorsi DJ, Johlin FC. Endoscopic retrograde cholangio-pancreatography-obtained bile culture can guide antibiotic therapy in acute cholangitis. Dig Dis. 2019;37(2):155-160. https://doi.org/10.1159/000493579 PMID:30282078

Masadeh M, Chandra S, Livorsi D, Johlin F, Silverman W. Evaluation of biliary bacterial resistance in patients with frequent biliary instrumentation, one size does not fit all. Dig Dis Sci. 2018;63(12):3474-3479. https://doi.org/10.1007/s10620-018-5263-5 PMID:30155838

Kwakman JA, Erler NS, Vos MC, Bruno MJ. Risk evaluation of duodenoscope-associated infections in the Netherlands calls for a heightened awareness of device-related infections: a systematic review. Endoscopy. 2022;54(2):148-155. https://doi.org/10.1055/a-1467-6294 PMID:33915575

Gastmeier P, Vonberg RP. Klebsiella spp. in endoscopy-associated infections: we may only be seeing the tip of the iceberg. Infection. 2014;42(1):15-21. https://doi.org/10.1007/s15010-013-0544-6 PMID:24166131

Deb A, Perisetti A, Goyal H, et al. Gastrointestinal endoscopy-associated infections: update on an emerging issue. Dig Dis Sci. 2022;67(5):1718-1732. https://doi.org/10.1007/s10620-022-07441-8 PMID:35262904

Petersen BT, Koch J, Ginsberg GG. Infection using ERCP endoscopes. Gastroenterology. 2016;151(1):46-50. https://doi.org/10.1053/j.gastro.2016.05.040 PMID:27240902

Aumeran C, Poincloux L, Souweine B, et al. Multidrug-resistant Klebsiella pneumoniae outbreak after endoscopic retrograde cholangiopancreatography. Endoscopy. 2010;42(11):895-899. https://doi.org/10.1055/s-0030-1255647 PMID:20725887

Kim S, Russell D, Mohamadnejad M, et al. Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes. Gastrointest Endosc. 2016;83(6):1121-1129. https://doi.org/10.1016/j.gie.2016.03.790 PMID:26993149

Hutfless S, Shiratori Y, Chu D, Liu S, Kalloo A. Risk factors for infections after endoscopic retrograde cholangiopancreatography (ERCP): a retrospective cohort analysis of US Medicare Fee-For-Service claims, 2015-2021. BMJ Open. 2022;12(9):e065077. https://doi.org/10.1136/bmjopen-2022-065077 PMID:36691191

Cennamo V, Landi S, Aragona G, et al. The management of endoscopic retrograde cholangio-pancreatography-related infections risk: results of an Italian survey at regional level. Ann Ig. 2023;35(1):84-91. PMID:35442386

Ayres AM, Wozniak J, O’Neil J, et al. Endoscopic retrograde cholangiopancreatography and endoscopic ultrasound endoscope reprocessing: variables impacting contamination risk. Infect Control Hosp Epidemiol. 2023;44(9):1485-1489. https://doi.org/10.1017/ice.2022.319 PMID:36645014

Conti CB, Cereatti F, Salerno R, et al. Disposable duodenoscopes: evidence and open issues. Life (Basel). 2023;13(8):1694. https://doi.org/10.3390/life13081694 PMID:37629551

Larsen S, Russell RV, Ockert LK, et al. Rate and impact of duodenoscope contamination: a systematic review and meta-analysis. EClinicalMedicine. 2020;25:100451. https://doi.org/10.1016/j.eclinm.2020.100451 PMID:32954234

Rauwers AW, Kwakman JA, Vos MC, Bruno MJ. Endoscope-associated infections: a brief summary of the current state and views toward the future. Tech Gastrointest Endosc. 2019;21(4):150608. https://doi.org/10.1016/j.tgie.2019.04.006

Rahman MR, Perisetti A, Coman R, Bansal P, Chhabra R, Goyal H. Duodenoscope-associated infections: update on an emerging problem. Dig Dis Sci. 2019;64(6):1409-1418. https://doi.org/10.1007/s10620-018-5431-7 PMID:30569333

Epstein L, Hunter JC, Arwady MA, et al. New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014;312(14):1447-1455. https://doi.org/10.1001/jama.2014.12720 PMID:25291580

Dabaja-Younis HK, Schechner V, Firan I, et al. Identification and control of two outbreaks of unrelated New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli traced to the same endoscope defect. Infect Control Hosp Epidemiol. 2023;44(10):1673-1675. https://doi.org/10.1017/ice.2023.21 PMID:36815278

Humphries RM, Yang S, Kim S, et al. Duodenoscope-related outbreak of a carbapenem-resistant Klebsiella pneumoniae identified using advanced molecular diagnostics. Clin Infect Dis. 2017;65(7):1159-1166. https://doi.org/10.1093/cid/cix527 PMID:29579235

Cristina ML, Sartini M, Schinca E, et al. Is post-reprocessing microbiological surveillance of duodenoscopes effective in reducing the potential risk in transmitting pathogens? Int J Environ Res Public Health. 2019;17(1):140. https://doi.org/10.3390/ijerph17010140 PMID:31878150

Fugazza A, Lamonaca L, Craviotto V, et al. Duodenoscope-related infections: an Italian pick in 2019. Gastrointest Endosc. 2020;91(6):AB369. https://doi.org/10.1016/j.gie.2020.03.2382

Ministero della Salute. Rapporto annuale sull'attività di ricovero ospedaliero (Dati SDO 2019). 2020. https://www.salute.gov.it/imgs/C_17_pubblicazioni_3277_allegato.pdf

Riesco-López JM, Vázquez-Romero M, Rizo-Pascual JM, et al. Efficacy and safety of ERCP in a low-volume hospital 105, no. 2 68-73. s.l. Rev Esp Enferm Dig. 2013. https://doi.org/10.4321/S1130-01082013000200002

Kuduva Rajan S, Madireddy S, Jaladi PR, et al. Burdens of postoperative infection in endoscopic retrograde cholangiopancreatography inpatients. Cureus. 2019;11(7):e5237. https://doi.org/10.7759/cureus.5237 PMID:31511812

Bhurwal A, Pioppo L, Reja M, et al. Post ERCP bacteremia and post ERCP fever leads to early unplanned readmission – incidence and outcomes. Gastrointest Endosc. 2020;91(6):AB349-AB350. https://doi.org/10.1016/j.gie.2020.03.2210

Published

2024-12-31

How to Cite

Sciattella, P., Fornero, A., Giordano, S., De Angelis, C., & Cattel, F. (2024). The economic burden of post-endoscopic retrograde cholangiopancreatography (ERCP) procedure infections in Italy. Global and Regional Health Technology Assessment, 11(1), 258–264. https://doi.org/10.33393/grhta.2024.3186

Issue

Section

Original Research Articles

Categories

Received 2024-06-29
Accepted 2024-11-12
Published 2024-12-31

Metrics

Most read articles by the same author(s)